Imagine a weather app that doesn't just tell you it's hot, but warns pregnant women and new moms exactly when the heat becomes dangerous for their babies. It also looks at how to keep clinics cool using simple tricks like white paint on roofs to protect both patients and doctors. The goal is to stop heat-related health crises before they happen using data and smart building tweaks.
Extreme heat reduces the productivity of health workers and increases adverse health outcomes for vulnerable mothers and infants. There is a lack of precise monitoring tools and low-cost facility adaptations to mitigate these risks.
["ClimApp EWS prototype: A smartphone app for personalized heat warnings.", "Risk assessment tool: A system to quantify heat impacts on health.", "Mitigation modelling tool: Software to simulate cooling interventions like reflective paint."]
If you are a developer dealing with low user engagement in prenatal care — this project developed the ClimApp-MCH prototype that delivers personalized heat alerts and setting-specific messages to 600 mothers and infants.
If you are a firm dealing with high energy costs in healthcare facilities — this project developed a tool for modelling alternative mitigation interventions, such as passive cooling and reflective white roof paint.
If you are a manager dealing with heat-related productivity drops among staff — this project developed a risk assessment tool and time-motion studies to document and reduce heat exposure for health workers.
Based on available project data, specific pricing is not provided, but the project includes analyses weighing costs and benefits across all activities.
The project tests its systems across 10 countries in Europe and Africa, suggesting a design intended for global scalability through WHO and UNICEF guidance.
Based on available project data, licensing terms are not specified, though the project involves 11 partners including universities and research organizations.
The project aims to release a final set of indicators in a WHO, UNICEF, and UNFPA guidance document to inform national and global policy.
The project runs from 2022-09-01 to 2026-11-30, with prototype evaluation currently occurring among mother-child cohorts.
The consortium is heavily weighted toward academic and research institutions (7 universities, 3 research centers), representing 91% of the partners. With only 1 industry partner (9% ratio), the project is primarily driven by scientific validation rather than commercial speed, though the inclusion of WHO and UNICEF ensures high-level policy integration.
Universiteit Gent
Contact us to bridge the gap between these clinical prototypes and commercial health-tech deployment.
